-
Signature
-
/s/ Raymond Bussiere as authorized signatory for Earl H. Nemser
-
Stock symbol
-
IBKR
-
Transactions as of
-
Jul 31, 2025
-
Transactions value $
-
-$1,793,965
-
Form type
-
4
-
Date filed
-
8/4/2025, 04:02 PM
Reporting Owners (1)
Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
Nemser Earl H |
Vice Chairman, Director |
ONE PICKWICK PLAZA, GREENWICH |
/s/ Raymond Bussiere as authorized signatory for Earl H. Nemser |
2025-08-04 |
0001391400 |
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
IBKR |
Class A common stock |
Sale |
-$823K |
-12.4K |
-1.64% |
$66.18 |
748K |
Jul 31, 2025 |
by EN Holdings LLC |
F1, F2 |
transaction |
IBKR |
Class A common stock |
Sale |
-$147K |
-2.2K |
-0.29% |
$66.71 |
745K |
Jul 31, 2025 |
by EN Holdings LLC |
F1, F3 |
transaction |
IBKR |
Class A common stock |
Sale |
-$75.3K |
-1.2K |
-0.16% |
$62.79 |
744K |
Aug 1, 2025 |
by EN Holdings LLC |
F1, F4 |
transaction |
IBKR |
Class A common stock |
Sale |
-$476K |
-7.44K |
-1% |
$63.94 |
737K |
Aug 1, 2025 |
by EN Holdings LLC |
F1, F5 |
transaction |
IBKR |
Class A common stock |
Sale |
-$207K |
-3.2K |
-0.43% |
$64.71 |
734K |
Aug 1, 2025 |
by EN Holdings LLC |
F1, F6 |
transaction |
IBKR |
Class A common stock |
Sale |
-$65.7K |
-1K |
-0.14% |
$65.66 |
733K |
Aug 1, 2025 |
by EN Holdings LLC |
F1, F7 |
holding |
IBKR |
Class A common stock |
|
|
|
|
|
428K |
Jul 31, 2025 |
Direct |
F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: